Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
HSCS
HeartSciences Inc.
CAPPED RATING
HeartSciences Inc. (HSCS) is rated C- (2.1/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (A-); its weakest is Value (F).
Quantitative Factor Evaluation • Updated
Overall Rating
2.1
/ 5.0
C-
Value
F
Factor Score
0.0
/ 5.0
Growth
C+
Factor Score
2.6
/ 5.0
Profitability
D
Factor Score
1.3
/ 5.0
Momentum
A-
Factor Score
4.0
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
-1.3
EV / EBITDA
-1.6
Rev Growth YoY
10.5%
Gross Margin
60.9%
Price Return 3M
11.4%
Price Return 12M
-18.0%
Catalyst Signal
0.00
Market Cap
$11.4M
TTM Revenue
$4.5K
Price / Sales
2.5K
ROE
N/M
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-12 | F (0.0) | C+ (2.6) | D (1.3) | A- (4.0) | C+ (2.6) | C- (2.1) |
| 2026-11-05 | F (0.0) | C+ (2.6) | D (1.3) | A (4.4) | C+ (2.7) | C (2.2) |
| 2026-10-29 | F (0.0) | C+ (2.5) | D (1.3) | A (4.4) | C+ (2.7) | C (2.2) |
| 2026-10-22 | F (0.0) | C+ (2.5) | D (1.3) | A (4.4) | C+ (2.6) | C (2.2) |
| 2026-10-15 | F (0.0) | C+ (2.5) | D (1.3) | B+ (3.7) | C+ (2.6) | C- (2.0) |
Page
1
of
4